SCHEMBL19089836

SCHEMBL19089836

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4ccc(-c5ccc(C67CC8CC(CC(C8)C6)C7)cc5)cc4)cc3)c3ccccc3-c3ccc4ccccc4c3)cc21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ MEN1 O00255 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ THRB P10828 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ NR2E1 Q9Y466 1/20 0.31
▸ RARA P10276 2/20 0.30
▸ RARB P10826 2/20 0.30
▸ RARG P13631 2/20 0.30
▸ NR1I2 O75469 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ PGR P06401 1/20 0.30
▸ HSPD1 P10809 1/20 0.30
▸ GOT1 P17174 1/20 0.30
▸ GLRA1 P23415 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ HSPE1 P61604 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19089894 1.00 PRMT5 (0.32) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL20648253 0.94 MEN1 (0.32) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL20648587 0.94 MEN1 (0.32) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL19098249 0.94 MEN1 (0.32) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL19098023 0.94 MEN1 (0.32) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL19089845 0.93 MEN1 (0.35) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL19098000 0.93 MEN1 (0.33) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL22517319 0.93 MEN1 (0.33) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL19098018 0.93 MEN1 (0.33) PRMT5WDR77MEN1KMT2ATHRB
SCHEMBL19098339 0.92 RARB (0.35) PRMT5WDR77MEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941108-B2 Organic compound and organic electroluminescent element comprising same MATERIAL SCIENCE CO., LTD. 2021-03-09 — — US disclosed
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-17 — — US disclosed
WO-2017116167-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 머티어리얼사이언스 주식회사 2017-07-06 — — WO disclosed
WO-2017116168-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 머티어리얼사이언스 주식회사 2017-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10941108-B2 Organic compound and organic electroluminescent element comprising same OCIAD2, OR51E2, OCIAD1 PRMT5 2792/4885WDR77 4070/4885MEN1 3245/4885
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OCIAD2, OR51E2, OCIAD1 PRMT5 2792/4885WDR77 4070/4885MEN1 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback